Chlorosartan potassium hydrochlorothiazide tablets are renin-angiotensin system drugs, a combination preparation of angiotensin II receptor antagonists and diuretics. Chlorosartan Potassium Hydrochlorothiazide Tablets, the main ingredients of which are Chlorosartan Potassium and Hydrochlorothiazide, is a single tablet compound preparation composed of two antihypertensive drugs, of which Chlorosartan Potassium belongs to the renin-angiotensin II receptor antagonist, and Hydrochlorothiazide is a diuretic. These two antihypertensive drugs can play a synergistic role in lowering blood pressure, therefore, chlorosartan potassium hydrochlorothiazide tablets are suitable for patients with hypertension treated with a combination of drugs. Adverse reactions such as anorexia, hyperglycemia, blurred vision and abdominal pain may occur in a small number of patients taking this drug. The vast majority of adverse reactions are relatively mild and transient, and do not require interruption of treatment, but if serious and persistent adverse reactions occur, they should be communicated with the doctor in a timely manner, and adjustments to the medication should be given if necessary. Chlorosartan potassium hydrochlorothiazide tablets should be prohibited for patients with anuria, hypersensitivity to other sulfonamides, and women during pregnancy. Chlorosartan potassium hydrochlorothiazide tablets are prescription drugs, patients should follow the doctor’s instructions to standardize the use of medication, not blindly self-use, to avoid the risk of medication.